Translation of cell therapies to the clinic: Characteristics of cell suspensions in large-diameter injection cannulae

Cell Transplantation

Volumn 24, Issue 4, 2015, Pages 737-749

  Torres, Eduardo M ^a   Trigano, Matthieu ^b   Dunnett, Stephen B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Cell suspensions; Cell transplantation; Implantation instrument; Sedimentation; Settling; Surgical cannula

Indexed keywords

GLASS; METAL;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANNULA; CELL ADHESION; CELL SUSPENSION; CELLULAR DISTRIBUTION; CLINICAL PROTOCOL; EMBRYO; EMBRYO CELL; NERVOUS TISSUE; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; SYRINGE; TARGET ORGAN; ANIMAL; ANIMAL EMBRYO; BIOLOGICAL THERAPY; BRAIN; CATHETER; CELL SEPARATION; CHEMISTRY; CYTOLOGY; DEVICES; HUMAN;

ANIMALS; BRAIN; CATHETERS; CELL SEPARATION; CELL- AND TISSUE-BASED THERAPY; EMBRYO, MAMMALIAN; HUMANS; METALS; RATS;

EID: 84927603301     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368914X685429     Document Type: Article

References (41)

1. Aguado, B. A.; Mulyasasmita, W.; Su, J.; Lampe, K. J.; Heilshorn, S. C. Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng. Part A 18:806–815; 2012.
2. Arvidsson, A.; Collin, T.; Kirik, D.; Kokaia, Z.; Lindvall, O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8:963–970; 2002.
3. Astradsson, A.; Mendez, I.; Vinuela, A.; Hallett, P.; Mukhida, K.; Robertson, H.; Tierney, T.; Holness, R.; Dagher, A.; Isacson, O. Long-term survival of functional fetal dopamine cell suspension transplants in Parkinson’s disease. Cell Transplant. 17:459; 2008.
4. Bjorklund, A.; Cenci, M. A. Neural grafting in Parkinson’s disease: Problems and possibilities. Prog. Brain Res. 184: 265–294; 2010.
5. Breeze, R. E.; Wells, T. H.; Freed, C.R. Implantation of fetal tissue for the management of Parkinsons disease - A technical note. Neurosurgery 36:1044–1047; 1995.
6. Brundin, P. Is there a future for cell transplantation in Parkinson’s disease? Eur. J. Neurol. 14:2–3; 2007.
7. Brundin, P.; Bjorklund, A.; Lindvall, O. Practical aspects of the use of human fetal brain tissue for intracerebral grafting. Prog. Brain Res. 82:707–714; 1990.
8. Brundin, P.; Pogarell, O.; Hagell, P.; Piccini, P.; Widner, H.; Schrag, A.; Kupsch, A.; Crabb, L.; Odin, P.; Gustavii, B.; Bjorklund, A.; Brooks, D. J.; Marsden, C. D.; Oertel, W. H.; Quinn, N. P.; Rehncrona, S.; Lindvall, O. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson’s disease. Brain 123(Pt 7):1380–1390; 2000.
9. Defer, G. L.; Geny, C.; Ricolfi, F.; Fenelon, G.; Monfort, J. C.; Remy, P.; Villafane, G.; Jeny, R.; Samson, Y.; Keravel, Y.; Gaston, A.; Degos, J. D.; Peschanski, M.; Cesaro, P.; Nguyen, J. P. Long-term outcome of unilaterally transplanted Parkinsonian patients. I. Clinical approach. Brain 119(Pt 1):41–50; 1996.
10. Dunnett, S. B. Towards a neural transplantation therapy for Parkinson’s disease: Experimental principles from animal studies. Acta Neurochir. Suppl. 52:35–38; 1991.
11. Dunnett, S. B.; Rogers, D. C.; Richards, S. J. Nigrostriatal reconstruction after 6-ohda lesions in rats - Combination of dopamine-rich nigral grafts and nigrostriatal bridge grafts. Exp. Brain Res. 75:523–535; 1989.
12. Dunnett, S. B.; Rosser, A. E. Challenges for taking primary and stem cells into clinical neurotransplantation trials for neurodegenerative disease. Neurobiol. Dis. 61:79–89; 2014.
13. Dunnett, S. B.; Svendsen, C. N. Huntington’s disease: Animal models and transplantation repair. Curr. Opin. Neurobiol. 3:790–796; 1993.
14. Freed, C. R.; Greene, P. E.; Breeze, R. E.; Tsai, W. Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J. Q.; Eidelberg, D.; Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N. Engl. J. Med. 344:710–719; 2001.
15. Freeman, T. B.; Olanow, C. W.; Hauser, R. A.; Nauert, G. M.; Smith, D. A.; Borlongan, C. V.; Sanberg, P. R.; Holt, D. A.; Kordower, J. H.; Vingerhoets, J. G.; Snow, B. J.; Calne, D.; Gauger, L. I. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinsons-disease. Ann. Neurol. 38:379–388; 1995.
16. Grover, W. H.; Bryan, A. K.; Diez-Silva, M.; Suresh, S.; Higgins, J. M.; Manalis, S. R. Measuring single-cell density. Proc. Natl. Acad. Sci. USA 108:10992–10996; 2011.
17. Kang, U. J.; Lee, W. Y.; Chang, J. W. Gene therapy for Parkinson’s disease: Determining the genes necessary for optimal dopamine replacement in rat models. Hum. Cell 14: 39–48; 2001.
18. Kondziolka, D.; Steinberg, G. K.; Cullen, S. B.; McGrogan, M. Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke. Cell Transplant. 13: 749–754; 2004.
19. Kopyov, O. V.; Jacques, D.; Lieberman, A.; Duma, C. M.; Rogers, R. L. Outcome following intrastriatal fetal mesencephalic grafts for Parkinson’s patients is directly related to the volume of grafted tissue. Exp. Neurol. 146:536–545; 1997.
20. Kurowska, Z.; Englund, E.; Widner, H.; Lindvall, O.; Li, J. Y.; Brundin, P. Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson’s disease. J. Park. Dis. 1:83–92; 2011.
21. Lassen, K. M. K.; de Caldeano, P. R. E. C.; Emborg, C. Methods for cell separation based on sedimentation. Biotechnol. Tech. 6:121–126; 1992.
22. Launiere, C. A.; Czaplewski, G. J.; Myung, J. H.; Hong, S.; Eddington, D. T. Rheologically biomimetic cell suspensions for decreased cell settling in microfluidic devices. Biomed. Microdev. 13:549–557; 2011.
23. Lindvall, O.; Kokaia, Z. Stem cells for the treatment of neurological disorders. Nature 441:1094–1096; 2006.
24. Lindvall, O.; Rehncrona, S.; Brundin, P.; Gustavii, B.; Astedt, B.; Widner, H.; Lindholm, T.; Bjorklund, A.; Leenders, K. L.; Rothwell, J. C. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson’s disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46:615–631; 1989.
25. Lopez, W. O. C.; Nikkhah, G.; Kahlert, U. D.; Maciaczyk, D.; Bogiel, T.; Moellers, S.; Schultke, E.; Dobrossy, M.; Maciaczyk, J. Clinical neurotransplantation protocol for Huntington’s and Parkinson’s disease. Rest. Neurol. Neurosci. 31:579–595; 2013.
26. Ma, Y. L.; Feigin, A.; Dhawan, V.; Fukuda, M.; Shi, Q. H.; Greene, P.; Breeze, R.; Fahn, S.; Freed, C.; Eidelberg, D. Dyskinesia after fetal cell transplantation for Parkinsonism: A PET study. Ann. Neurol. 52:628–634; 2002.
27. Mazzini, L.; Ferrero, I.; Luparello, V.; Rustichelli, D.; Gunetti, M.; Mareschi, K.; Testa, L.; Stecco, A.; Tarletti, R.; Miglioretti, M.; Fava, E.; Nasuelli, N.; Cisari, C.; Massara, M.; Vercelli, R.; Oggioni, G. D.; Carriero, A.; Cantello, R.; Monaco, F.; Fagioli, F. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp. Neurol. 223:229–237; 2010.
28. Mendez, I.; Dagher, A.; Hong, M.; Gaudet, P.; Weerasinghe, S.; McAlister, V.; King, D.; Desrosiers, J.; Darvesh, S.; Acorn, T.; Robertson, H. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: A pilot study. Report of three cases. J. Neurosurg. 96:589–596; 2002.
29. Mendez, I.; Hong, M.; Smith, S.; Dagher, A.; Desrosiers, J. Neural transplantation cannula and microinjector system: Experimental and clinical experience - Technical note. J. Neurosurg. 92:493–499; 2000.
30. Nikkhah, G.; Cunningham, M. G.; Jodicke, A.; Knappe, U.; Bjorklund, A. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res. 633:133–143; 1994.
31. Nikkhah, G.; Rosenthal, C.; Falkenstein, G.; Roedter, A.; Papazoglou, A.; Brandis, A. Microtransplantation of dopaminergic cell suspensions: Further characterization and optimization of grafting parameters. Cell Transplant. 18: 119–133; 2009.
32. Olanow, C. W.; Goetz, C. G.; Kordower, J. H.; Stoessl, A. J.; Sossi, V.; Brin, M. F.; Shannon, K. M.; Nauert, G. M.; Perl, D. P.; Godbold, J.; Freeman, T. B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann. Neurol. 54:403–414; 2003.
33. Peschanski, M.; Defer, G.; Nguyen, J. P.; Ricolfi, F.; Monfort, J. C.; Remy, P.; Geny, C.; Samson, Y.; Hantraye, P.; Jeny, R.; Gaston, A.; Keravel, Y.; Degos, J. D.; Cesaro, P. Bilateral motor improvement and alteration of L-dopa effect in 2 patients with Parkinsons-disease following intrastriatal transplantation of fetal ventral mesencephalon. Brain 117:487–499; 1994.
34. Potts, M. B.; Silvestrini, M. T.; Lim, D. A. Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies. Surg. Neurol. Int. 4(Suppl 1):S22–S30; 2013.
35. Rosser, A. E.; Barker, R. A.; Harrower, T.; Watts, C.; Farrington, M.; Ho, A. K.; Burnstein, R. M.; Menon, D. K.; Gillard, J. H.; Pickard, J.; Dunnett, S. B. Unilateral transplantation of human primary fetal tissue in four patients with Huntington’s disease: NEST-UK safety report ISRCTN no 36485475. J. Neurol. Neurosurg. Psychiatry 73:678–685; 2002.
36. Rosser, A. E.; Zietlow, R.; Dunnett, S. B. Stem cell transplantation for neurodegenerative diseases. Curr. Opin. Neurol. 20:688–692; 2007.
37. Schumacher, J. M.; Ellias, S. A.; Palmer, E. P.; Kott, H. S.; Dinsmore, J.; Dempsey, P. K.; Fischman, A. J.; Thomas, C.; Feldman, R. G.; Kassissieh, S.; Raineri, R.; Manhart, C.; Penney, D.; Fink, J. S.; Isacson, O. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54:1042–1050; 2000.
38. Torres, E. M.; Dowd, E.; Dunnett, S. B. Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson’s disease. Neuroscience 154:631–640; 2008.
39. Wenning, G. K.; Odin, P.; Morrish, P.; Rehncrona, S.; Widner, H.; Brundin, P.; Rothwell, J. C.; Brown, R.; Gustavii, B.; Hagell, P.; Jahanshahi, M.; Sawle, G.; Bjorklund, A.; Brooks, D. J.; Marsden, C. D.; Quinn, N. P.; Lindvall, O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson’s disease. Ann. Neurol. 42:95–107; 1997.
40. Wyse, R. D.; Dunbar, G. L.; Rossignol, J. Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases. Int. J. Mol. Sci. 15:1719–1745; 2014.
41. Yang, N.; Wernig, M. A case for neural stem cell therapy. Nat. Med. 19:1580–1581; 2013.